Hakata Clinic Medical Co. LTA   Report issue

For profit Phase 1
Founded: Fukuoka Japan (1989)

Organization Overview

First Clinical Trial
2010
NCT01293357
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Hakata Clinic | Hakata Clinica LTA Clinical Pharmacology Center | Hakata Clinic LTA Clinical Pharmacology Center

Active Ingredients

Drugs in Phase 1 Trials (2)

d961 (2 trials)

leo 90105 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis, Phototoxic (Phase 1)

Duodenal Ulcer (Phase 1)

Esophagitis (Phase 1)

Esophagitis, Peptic (Phase 1)

Stomach Ulcer (Phase 1)

Ulcer (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 2